Clinical trial
The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma
NCT04014738 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 20, 2019
- Completion date
- December 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.